Characterization of dihydropyrimidine dehydrogenase in human colorectal tumours.

Dihydropyrimidine dehydrogenase (DPD) is the rate-limiting enzyme for degradation of 5-fluorouracil (5-FU). DPD activity is highly variable in liver and peripheral mononuclear cells (PMNCs) and it has not been well studied in human tumours. Characterization of DPD in colorectal cancer is of clinical...

Descripción completa

Detalles Bibliográficos
Autores principales: McLeod, H. L., Sludden, J., Murray, G. I., Keenan, R. A., Davidson, A. I., Park, K., Koruth, M., Cassidy, J.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1998
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2151304/
https://www.ncbi.nlm.nih.gov/pubmed/9472644

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2151304/
https://www.ncbi.nlm.nih.gov/pubmed/9472644

Ejemplares similares